A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin

NCT00530946 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Hypercholesterolemia

Interventions

DRUG: Amlodipine 2.5mg/Atorvastatin 5mg
DRUG: Amlodipine 2.5mg/Atorvastatin 10mg
DRUG: Amlodipine 5mg/Atorvastatin 5mg
DRUG: Amlodipine 5mg/Atorvastatin 10mg

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.